Darden Restaurants leads the positive analyst action today. The DRI consensus target price rose to $226.23, up from $225.58. The restaurant operator holds a strong buy-leaning consensus with 18 buy ratings. Short interest sits at just 5.1% of free float.
Homebuilder LEN faces pressure. Analysts trimmed the average target to $89.50 from $90.14. The housing sector remains in focus as affordability concerns weigh on sentiment. Short interest at 8.8% of free float reflects ongoing bearish positioning.
GILD scored an upward target price revision today. The average consensus price climbed to $157.57 from $157.04. Gilead carries 23 hold ratings and zero sells — a rare profile for a $156 billion biopharma.
BIIB saw the opposite treatment. The Biogen average target slipped to $220.13. With 21 sell ratings against just one buy, the consensus on the Alzheimer drug maker remains deeply cautious.
GIS also took a target cut. General Mills dropped to $37.00 from $37.56 as the packaged food sector struggles with volume pressure and shifting consumer habits.
SCHW and MTB both received upward target revisions. Both regional financial names benefit from a steeper yield curve and improving net interest margin expectations.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
